@vrs37 - you posted that "from what I can see their trial shares lot of similarity with dmx fgs phase 3 trial, like the same endpoints and length"
This is a very different view than that articulated in a recent Investor Presentation in a DXB announcement - where they claimed there is NO comparison with Travere's Duplex trial (see slide below).
I like contrary views that are based on science and logical argument, but I don't like manipulative innuendo.
While not, at this moment, accusing you of the latter, I would like to see your more detailed arguments as to why you are correct and why Dimerix management is not. Unsubstantiated statements or inferences are completely worthless!
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-389
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
53.0¢ |
Change
0.020(3.92%) |
Mkt cap ! $291.6M |
Open | High | Low | Value | Volume |
51.0¢ | 53.8¢ | 51.0¢ | $782.0K | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6408 | 53.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.5¢ | 35657 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6408 | 0.530 |
2 | 48000 | 0.525 |
6 | 113118 | 0.520 |
4 | 57872 | 0.515 |
14 | 177420 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.535 | 35657 | 1 |
0.540 | 75830 | 5 |
0.545 | 232172 | 7 |
0.550 | 73893 | 6 |
0.555 | 120000 | 2 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online